Carlos Alban
2020
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $5,629,242 |
|---|---|
| Non-Equity Incentive Plan | $2,475,000 |
| Option Awards | $1,390,831 |
| Salary | $1,211,808 |
| Stock Awards | $5,822,401 |
| Other | $324,644 |
| Total | $16,853,926 |
Alban received $5.8M in stock awards, accounting for 35% of the total pay in 2020.
Alban also received $5.6M of change in pension value and nonqualified deferred compensation earnings, $2.5M in non-equity incentive plan, $1.4M in option awards, $1.2M in salary and $324.6K in other compensation.
Rankings
In 2020, Carlos Alban's compensation ranked 316th out of 13,090 executives tracked by ExecPay. In other words, Alban earned more than 97.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 316 out of 13,090 | 98th |
Division Manufacturing | 105 out of 5,621 | 98th |
Major group Chemicals And Allied Products | 35 out of 2,254 | 98th |
Industry group Drugs | 31 out of 1,954 | 98th |
Industry Pharmaceutical Preparations | 22 out of 1,459 | 99th |
Pay ratio
| Carlos Alban's Pay | $16,853,926 |
|---|---|
| Median Employee's Pay | $155,772 |
| Pay Ratio | 108to 1 |
In 2020, the annual total compensation of Carlos Alban was $16,853,926.
The annual total compensation of the median employee at AbbVie was $155,772.
The ratio of Carlos Alban's pay to the pay of median employee was therefore 108 to one.
Alban's colleagues
We found four more compensation records of executives who worked with Carlos Alban at AbbVie in 2020.